Mohammad Javad Zibaeenezhad

Mohammad Javad Zibaeenezhad

Auto-generated profile, based on publicly available information

Mohammad Javad Zibaeenezhad

Cardiovascular Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2017 in Nutrition & Diabetes
Verified
Journal Article
Open access
PDF file
MZM J Zibaeenezhad
M J Zibaeenezhad
PFP Farhadi
P Farhadi
AAA Attar
A Attar
AMA Mosleh
A Mosleh
FAF Amirmoezi
F Amirmoezi
AAA Azimi
A Azimi
Background: The role of herbal medicine is now well documented in preventing and controlling diabetes mellitus. The main aim of this study was to evaluate the effects of walnut oil consumption on lipid profiles of hyperlipidemic patients with type 2 diabetes. Methods: In a randomized, double-blind, placebo-controlled clinical trial, 100 hyperlipidemic type 2 diabetic patients aged 35–75 years were assigned to receive 15 cc Persian walnut oil or placebo every day for 90 days. The primary outcomes were the lipid profiles. Results: Consumption of walnut oil by type 2 hyperlipidemic diabetic patients resulted in a significant decrease in total cholesterol levels (treatment difference (TD)=−30.04, P<0.001), triglyceride (TG) level (TD=−15.04, P=0.021), low-density lipoprotein (LDL) level (TD=−30.44, P<0.001) and total cholesterol to high-density lipoprotein (HDL) ratio (TD=−0.72, P<0.001) compared to the control group. There was a trend toward increasing HDL level with consumption of walnut oil (TD=2.28, P=0.06). Frequency of patients reaching a LDL level below 100 was higher in the case group (20 vs 0%). Conclusions: Addition of walnut oil in the daily diet of type 2 diabetic patients improves lipid profiles. Thus, it may be associated with a coronary artery disease risk factor modulation. Also, walnut oil may serve as a helpful natural remedy for hyperlipidemic patients with type 2 diabetes.

1 January 2017 in Journal of Clinical Lipidology
Verified
Journal Article
Closed access
YFYasamin Fathi
Yasamin Fathi
NGNaeimeh Ghodrati
Naeimeh Ghodrati
MZMohammad-Javad Zibaeenezhad
Mohammad-Javad Zibaeenezhad
SFShiva Faghih
Shiva Faghih

5 February 2015 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
YFYasamin Fathi
Yasamin Fathi
SFShiva Faghih
Shiva Faghih
MZMohammad Javad Zibaeenezhad
Mohammad Javad Zibaeenezhad
STSayed Hamid Reza Tabatabaei
Sayed Hamid Reza Tabatabaei

9 February 2022 in Disease Markers
Verified
Journal Article
Open access
PDF file
RIRazeghian-Jahromi Iman
Razeghian-Jahromi Iman
AAAli Karimi Akhormeh
Ali Karimi Akhormeh
MZMohammad Javad Zibaeenezhad
Mohammad Javad Zibaeenezhad
There is a huge number of noncoding RNA (ncRNA) transcripts in the cell with important roles in modulation of different mechanisms. ANRIL is a long ncRNA with 3.8 kb length that is transcribed in the opposite direction of the INK4/ARF locus in chromosome 9p21. It was shown that polymorphisms within this locus are associated with vascular disorders, notably coronary artery disease (CAD), which is considered as a risk factor for life-threatening events like myocardial infarction and stroke. ANRIL is subjected to a variety of splicing patterns producing multiple isoforms. Linear isoforms could be further transformed into circular ones by back-splicing. ANRIL regulates genes in atherogenic network in a positive or negative manner. This regulation is implemented both locally and remotely. While CAD is known as a proliferative disorder and cell proliferation plays a crucial role in the progression of atherosclerosis, the functions of ANRIL and CAD development are intertwined remarkably. This makes ANRIL a suitable target for diagnostic, prognostic, and even therapeutic aims. In this review, we tried to present a comprehensive appraisal on different aspects of ANRIL including its location, structure, isoforms, expression, and functions. In each step, the contribution of ANRIL to atherosclerosis is discussed.

9 April 2022 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
FZFatemeh Zibaeenejad
Fatemeh Zibaeenejad
SMSeyyed Saeed Mohammadi
Seyyed Saeed Mohammadi
MSMehrab Sayadi
Mehrab Sayadi
FSFatemeh Safari
Fatemeh Safari
MZMohammad Javad Zibaeenezhad
Mohammad Javad Zibaeenezhad
Background: Atherosclerotic cardiovascular disease (ASCVD) continues to be the first cause of mortality globally. Effective preventive strategies require focused efforts to clarify ASCVD risk factors in different subgroups of a population. This study aimed to identify individuals at higher risk of ASCVD among Shiraz University employees to guide decision-making for primary prevention. Methods: This cohort-based cross-sectional study was conducted on data of 1191 participants (25–70 years old) from Shiraz University employees selected by systematic random sampling. The 10-year ASCVD risk was calculated with an ASCVD risk score estimator developed by the American College of Cardiology/American Heart Association (ACC/AHA). To analyze the data, descriptive and chi-square tests were used. All statistical analyses were conducted using the SPSS version 16.0 software. The p-value < 0.05 was considered a significant level. Results: This study demonstrated that 75.3% of the participants had low risk scores, whereas 13.2% and 2.5% of them had intermediate and high risk scores, respectively. Additionally, it revealed that among women 93.7%, 2.7%, and 0.6% had low intermediate and had high risk scores, respectively, whereas among men, 61.5%, 21.1%, and 3.9% had low intermediate and high risk scores, respectively. Based on the results of the chi-square test, men were significantly more prone to ASCVD (38.5%) than women (6.3%) were. Interestingly, 40.9% of known cases of hypertension had uncontrolled blood pressure, and 62.5% of individuals without any history of hypertension, who were considered new cases of hypertension, had abnormal blood pressure. Furthermore, 38.5% of diabetic patients and 1.6% of people who did not have a history of diabetes had abnormal serum fasting blood sugar. Conclusion: It was revealed that nearly 15.7% of participants were at intermediate and high risk of developing ASCVD in the next 10 years with greater risk in men. Considerably, some of hypertensive and diabetic participants had uncontrolled blood pressure and blood sugar levels, respectively. New cases of diabetes and hypertension were also recognized in our study. Therefore, to address the primary prevention of ASCVD in this population, it is necessary to have plans for targeted interventions, which can be effective in modifying their risk factors.

1 July 2003 in Angiology
Verified
Journal Article
Closed access
PDF file
MZM.J. Zibaeenezhad
M.J. Zibaeenezhad
MRM. Rezaiezadeh
M. Rezaiezadeh
AMA. Mowla
A. Mowla
SASeyyed Mohammad Taghi Ayatollahi
Seyyed Mohammad Taghi Ayatollahi
MPM.R. Panjehshahin
M.R. Panjehshahin
Hyperlipidemia is an important modifiable risk factor of coronary heart diseases. So far, several studies, have indicated the beneficial effects of nuts on plasma lipid profile. Previously, in a pilot study the authors have shown that administration of 20 g/day of Persian walnut (Juglans regia L.) for 8 weeks could decrease plasma triglyceride (TG) concentration by 17% (p value < 0.05). Walnut also increased the plasma HDL-cholesterol level markedly (p value < 0.05). To make the measurements more reliable and to avoid the unwanted walnut side effects (eg, rash, pruritus), this randomized, double blind case-control study was conducted to evaluate the lipid-lowering effect of Persian walnut oil in the population of southern Iran. Sixty hyper lipidemic subjects were randomized into 2 groups; group A patients (n = 29) received walnut oil encapsulated in 500 mg capsules, 3 g/day, for 45 days. Group B patients (n=31) received placebo and served as the control group. Lipid profiles of both groups were checked before; on days 15, 30, and 45 after the beginning; and 15 days after termination of the study. Plasma TG concentrations decreased by 19% to 33% of baseline in group A patients (p value < 0.05). No statistically significant change was observed in other measured parameters. It was concluded that walnut oil is a good antihypertriglyceridemic natural remedy and should be further explored in more detail.